Meril's HALO Stem Targets Indian Hip Anatomy with 135° Neck, 2.5° Taper

For healthcare providers and medical device teams, this launch signals a shift toward population-specific implant design. Indian patients have historically been fitted with implants based on Western datasets, which can compromise fit and long-term outcomes. Meril's surgeon-led, 3D CT morphometric approach could improve surgical precision and reduce revision burden, with implications for clinical documentation, surgical planning, and patient-specific care pathways.

On September 12, 2026, Meril Life Sciences, an India-based global medtech company, announced the simultaneous launch of the HALO (Hybrid Asian Low Offset) Stem and the Latitud Revision Acetabular Cup System. According to the company, the dual launch establishes a complete primary-to-revision ecosystem for total hip arthroplasty (THA), with a focus on anatomical reconstruction, stable fixation, and consistent implant positioning. The announcement was distributed through NewsVoir and syndicated by outlets in Bangladesh and Sri Lanka; it is a corporate press release rather than independent reporting, so launch timing, regulatory clearance, and clinical performance should be treated as company claims until confirmed by regulators or peer-reviewed data.

“

On September 12, 2026, Meril Life Sciences, an India-based global medtech company, announced the simultaneous launch of the HALO (Hybrid Asian Low Offset) Stem and the Latitud Revision Acetabular Cup System.

The strategic context is the long-standing reliance of the Indian orthopaedic market on imported Western implants. Those designs were overwhelmingly engineered from European and North American anatomical datasets. Meril asserts that Indian and Asian anatomies present distinct variations, including lower femoral offsets, narrower intramedullary canals, and smaller pelvic profiles. The company says this mismatch has driven a surgeon-led effort to create implants based on indigenous 3D CT scan morphometric studies of local patient populations. If validated, this represents a meaningful shift from off-the-shelf Western geometry toward population-specific hip arthroplasty design in India.

The HALO Stem incorporates a 135-degree neck angle and a moderate 2.5-degree taper angle. Meril describes ribbed geometry for rotational stability and fixation, extended ribs to support fixation and facilitate removal, a polished neck and distal tip for smoother insertion, and a blasted surface. These features are intended to address load transfer and fit in smaller Asian femora. The Latitud Revision Acetabular Cup System is positioned for revision hip arthroplasty, although the source text provides fewer geometric details for the cup itself. The combination aims to cover both primary and revision scenarios, which is important because revision cases often require more modularity and bone defect management.

Meril also highlights that hip replacement in India is increasingly relevant beyond older adults. Avascular necrosis, developmental conditions, trauma, and inflammatory arthritis can affect younger and active individuals. These patients require anatomical restoration and predictable long-term outcomes, not simply pain relief. A stem designed for lower femoral offsets and narrower canals may reduce the need for surgical adjustments and improve implant-bone contact in this demographic.

From a market perspective, the launch is part of a broader effort to reduce import dependence and strengthen India's domestic medtech capabilities. The Indian orthopaedic implant market has grown with increasing surgical volumes, but local manufacturers have historically struggled to gain share against multinational rivals because of trust, training infrastructure, and lack of local clinical data. Meril's emphasis on surgeon collaboration and CT morphometric studies could help build legitimacy, though independent registries and studies will be required. The dual product line may also position Meril to compete in revision arthroplasty, a segment with higher reimbursement complexity but strong clinical need.